Date | Description |
2023-04-21 |
delete ceo Avalyn Pharma |
2023-04-21 |
delete person Aleksandar Danilovski |
2023-04-21 |
delete person Avalyn Pharma |
2023-04-21 |
delete person Bruce Montgomery |
2023-04-21 |
delete person Carole Sable |
2023-04-21 |
delete person Gerald B. Pier |
2023-04-21 |
delete person Jennifer Leeds |
2023-04-21 |
delete person Lloyd Czaplewski |
2023-04-21 |
delete person Lloyd Payne |
2023-04-21 |
delete person Lynn L. Silver |
2023-04-21 |
delete person Ruben Tommasi |
2023-04-21 |
delete person Ursula Theuretzbacher |
2022-02-06 |
update person_title Carole Sable: Chief Medical Officer of Antabio and Principal of CA Sable Consulting; Physician => Principal of CA Sable Consulting; Physician |
2021-07-29 |
delete chairman John Rex |
2021-07-29 |
delete person John Rex |
2021-07-29 |
insert person Carole Sable |
2021-05-27 |
update person_title Camilla Petrycer Hansen: Senior Associate => Principal |
2019-10-31 |
insert ceo Søren Møller |
2019-10-31 |
delete source_ip 104.17.243.75 |
2019-10-31 |
delete source_ip 104.17.244.75 |
2019-10-31 |
insert source_ip 159.69.224.43 |
2019-10-31 |
update person_title Søren Møller: null => Managing Partner |
2019-07-02 |
delete about_pages_linkeddomain antibacterialdrugdevelopmentsummit.com |
2019-03-28 |
delete associated_investor New Leaf Venture Partners |
2019-03-28 |
delete person Liam Ratcliffe |
2019-03-28 |
delete source_ip 104.16.181.86 |
2019-03-28 |
delete source_ip 104.16.182.86 |
2019-03-28 |
delete source_ip 104.16.183.86 |
2019-03-28 |
delete source_ip 104.16.184.86 |
2019-03-28 |
delete source_ip 104.16.185.86 |
2019-03-28 |
insert person Camilla Petrycer Hansen |
2019-03-28 |
insert person Jennifer Leeds |
2019-03-28 |
insert source_ip 104.17.243.75 |
2019-03-28 |
insert source_ip 104.17.244.75 |